Description

[1,1'-Biphenyl]-4-Carboxylic Acid, 4-[4-(3-Chlorophenoxy)-3-Hydroxy-1-Butenyl]Hexahydro-2-Oxo-2H-Cyclop Enta[B]Furan-5-Yl Ester, [3Ar-[3Aa,4A(1E,3R*),5B,6Aa]] is a complex, high-purity synthetic intermediate with a defined stereochemistry. This compound is valued for its role as a critical building block in advanced organic synthesis, particularly for the development of novel active pharmaceutical ingredients (APIs). It is essential for research and development chemists in the pharmaceutical and agrochemical industries seeking to create new molecules with specific biological activities.

Application

• Pharmaceutical Intermediate: A key chiral precursor in the synthesis of novel therapeutic agents, particularly in steroid or prostaglandin-related drug discovery programs.
• Agrochemical Research: Used in the development of new generation pesticides and herbicides, leveraging its complex bicyclic and aromatic structure.
• Advanced Organic Synthesis: Serves as a sophisticated building block for constructing complex natural product analogs and other fine chemicals.
• Biochemical Research: Potential use as a probe or ligand in biochemical assays due to its specific three-dimensional conformation.
• Material Science Precursor: Can be utilized in the synthesis of specialized polymers or liquid crystals requiring rigid, multi-ring structures.

Basic Information

Product Name	[1,1'-Biphenyl]-4-Carboxylic Acid, 4-[4-(3-Chlorophenoxy)-3-Hydroxy-1-Butenyl]Hexahydro-2-Oxo-2H-Cyclop Enta[B]Furan-5-Yl Ester, [3Ar-[3Aa,4A(1E,3R*),5B,6Aa]]
CAS No.	54713-44-9
Molecular Formula	C32H31ClO6
Molecular Weight	547.04 g/mol
Synonyms	4-[4-(3-Chlorophenoxy)-3-hydroxy-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate; 4-[4-(3-Chlorophenoxy)-3-hydroxybut-1-en-1-yl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl 4-phenylbenzoate; 54713-44-9; UNII-8V8P15469W; 8V8P15469W; SCHEMBL233422; BCP31933; AOB67717.
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Every batch is characterized using advanced analytical techniques to confirm identity, purity, and stereochemical integrity. Certificates of Analysis (COA) detailing specific results for assay, chiral purity, and impurity profiles are available upon request. We adhere to cGMP guidelines for the production of materials intended for pharmaceutical research.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound may be hygroscopic (moisture-sensitive); ensure the container is sealed under an inert atmosphere if specified.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Chiral Purity	≥ 99.0% ee
Related Substances (HPLC)	Any single impurity ≤ 0.5%, Total impurities ≤ 1.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.